DaVita Inc. 2nd Quarter 2019 Results
DaVita Inc. (NYSE: DVA) today announced results for the quarter ended June 30, 2019. Second quarter 2019 financial highlights: Completed the sale of our DMG division to Optum. Consolidated revenues of
Uncategorized
This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
More in Uncategorized
DaVita Health Solutions Grows Leadership Team
DaVita Health Solutions today announced two additions to its leadership team: Dr. Dorothy “Dody” Fisher, national medical director, and Ian Laird, national vice president of growth. Dr. Fisher and…
Innovation in Home Care Delivery Improves the Quality of Life for More Kidney Patients
DaVita Kidney Care, a leading provider of kidney care services in the United States, announced today that growth of its peritoneal dialysis and home hemodialysis programs is four times the growth…
DaVita Commences Self-Tender Offer To Purchase For Cash Shares Of Its Common Stock For An Aggregate Purchase Price Of No More Than $1.2 Billion At A Purchase Price Of Not Less Than $53.50 Per Share And Not More Than $61.50 Per Share
DAVITA INC. (NYSE: DVA), “DaVita,” a Fortune 500® health care provider focused on transforming care delivery to improve quality of life for patients around the globe and the largest provider of…
DaVita Inc. Announces Preliminary Second Quarter 2019 Results and Updated Guidance for Fiscal Year 2019
DaVita Inc. (NYSE: DVA) (“DaVita” or “Company”), today announced preliminary second quarter 2019 financial and operating results and updated guidance for fiscal year 2019. The Company is releasing…